BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miller S, Hu SS, Leishman E, Morgan D, Wager-Miller J, Mackie K, Bradshaw HB, Straiker A. A GPR119 Signaling System in the Murine Eye Regulates Intraocular Pressure in a Sex-Dependent Manner. Invest Ophthalmol Vis Sci 2017;58:2930-8. [PMID: 28593245 DOI: 10.1167/iovs.16-21330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Murataeva N, Daily L, Taylor X, Dhopeshwarkar A, Hu SS, Miller S, McHugh D, Oehler O, Li S, Bonanno JA, Mackie K, Straiker A. Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea. Cornea 2019;38:905-13. [PMID: 30969262 DOI: 10.1097/ICO.0000000000001934] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
2 Biringer RG. Endocannabinoid signaling pathways: beyond CB1R and CB2R. J Cell Commun Signal 2021;15:335-60. [PMID: 33978927 DOI: 10.1007/s12079-021-00622-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Miller S, Daily L, Ploss M, Greig I, Ross R, Rayana NP, Dai J, Sugali CK, Mao W, Straiker A. Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms. Exp Eye Res 2020;200:108241. [PMID: 32941875 DOI: 10.1016/j.exer.2020.108241] [Reference Citation Analysis]
4 Markovics A, Angyal Á, Tóth KF, Ádám D, Pénzes Z, Magi J, Pór Á, Kovács I, Törőcsik D, Zouboulis CC, Bíró T, Oláh A. GPR119 Is a Potent Regulator of Human Sebocyte Biology. J Invest Dermatol 2020;140:1909-1918.e8. [PMID: 32142797 DOI: 10.1016/j.jid.2020.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Toguri J, Leishman E, Szczesniak A, Laprairie R, Oehler O, Straiker A, Kelly M, Bradshaw H. Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye. Prostaglandins & Other Lipid Mediators 2018;139:54-62. [DOI: 10.1016/j.prostaglandins.2018.09.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 Miller S, Daily L, Dharla V, Gertsch J, Malamas MS, Ojima I, Kaczocha M, Ogasawara D, Straiker A. Endocannabinoid metabolism and transport as targets to regulate intraocular pressure. Exp Eye Res 2020;201:108266. [PMID: 32979397 DOI: 10.1016/j.exer.2020.108266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chetoni P, Burgalassi S, Zucchetti E, Granchi C, Minutolo F, Tampucci S, Monti D. MAGL inhibitor NanoMicellar formulation (MAGL-NanoMicellar) for the development of an antiglaucoma eye drop. Int J Pharm 2022;:122078. [PMID: 35932931 DOI: 10.1016/j.ijpharm.2022.122078] [Reference Citation Analysis]
8 Hansen HS, Vana V. Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine. Br J Pharmacol 2019;176:1443-54. [PMID: 29473944 DOI: 10.1111/bph.14175] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
9 Vallée A, Lecarpentier Y, Vallée JN. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma. Int J Mol Sci 2021;22:3798. [PMID: 33917605 DOI: 10.3390/ijms22073798] [Reference Citation Analysis]
10 Murataeva N, Miller S, Dhopeshwarkar A, Leishman E, Daily L, Taylor X, Morton B, Lashmet M, Bradshaw H, Hillard CJ, Romero J, Straiker A. Cannabinoid CB2R receptors are upregulated with corneal injury and regulate the course of corneal wound healing. Exp Eye Res 2019;182:74-84. [PMID: 30905716 DOI: 10.1016/j.exer.2019.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
11 Jordan E, Nguyen GN, Piechot A, Kayser O. Cannabinoids as New Drug Candidates for the Treatment of Glaucoma. Planta Med 2022. [PMID: 35299275 DOI: 10.1055/a-1665-3100] [Reference Citation Analysis]
12 Thayer A, Murataeva N, Delcroix V, Wager-Miller J, Makarenkova HP, Straiker A. THC Regulates Tearing via Cannabinoid CB1 Receptors. Invest Ophthalmol Vis Sci 2020;61:48. [PMID: 32852544 DOI: 10.1167/iovs.61.10.48] [Reference Citation Analysis]
13 Rebibo L, Frušić-Zlotkin M, Ofri R, Nassar T, Benita S. The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure. Int J Pharm 2022;:121627. [PMID: 35245638 DOI: 10.1016/j.ijpharm.2022.121627] [Reference Citation Analysis]
14 Straiker A. What is currently known about cannabidiol and ocular pressure. Expert Review of Ophthalmology 2019;14:259-61. [DOI: 10.1080/17469899.2019.1698947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
15 Miller S, Daily L, Leishman E, Bradshaw H, Straiker A. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure. Invest Ophthalmol Vis Sci 2018;59:5904-11. [PMID: 30550613 DOI: 10.1167/iovs.18-24838] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
16 Mucke HA. Patent highlights from December 2017 to January 2018. Pharm Pat Anal 2018;7:111-9. [PMID: 29676211 DOI: 10.4155/ppa-2018-0003] [Reference Citation Analysis]